| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6099306 | Journal of Crohn's and Colitis | 2014 | 10 Pages |
Abstract
Adalimumab was successful in the majority of patients, with 10% loss of response per subsequent year. Concomitant thiopurines might improve adalimumab maintenance treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Charlotte P. Peters, Emma J. Eshuis, Florien M. Toxopeüs, Merel E. Hellemons, Jeroen M. Jansen, Geert R.A.M. D'Haens, Paul Fockens, Pieter C.F. Stokkers, Hans A.R.E. Tuynman, Adriaan A. van Bodegraven, Cyriel Y. Ponsioen,